Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samantha Pearce currently holds 47,911 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samantha Pearce has been a net seller of JAZZ stock. They have purchased $0 and sold $3.3M worth of shares.
Samantha Pearce's most recent insider trade was on Jun 30, 2026, when they sold 2,527 shares at $237.72 per share.
Samantha Pearce serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 38 insider transactions totaling $3.3M over their tenure at the company.
Samantha Pearce holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Samantha Pearce has shown a selling trading pattern, with $0 in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Samantha Pearce was on Jun 27, 2022, when they sold $1.3M worth of JAZZ shares. This transaction involved 8,508 shares at $155.00 per share.
Samantha Pearce currently owns 47,911 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samantha Pearce's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samantha Pearce has 38 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Samantha Pearce and 40,000+ other insiders.